US Animal Biotechnology Market 2024–2033

Reports Description

As per the current market research conducted by the CMI Team, the US Animal Biotechnology Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 13,019.9 Million. By 2033, the valuation is anticipated to reach USD 24,138.7 Million.

The US animal biotechnology market is defined in the research study as the development and application of technologies to advance animal health, productivity, and welfare. These include genetic engineering and advanced diagnostics, vaccines, and therapeutics to enhance livestock management and disease prevention.

The market is driven by increasing advancements in precision medicine, AI, & data analytics and rising consumer demands for transparency and sustainability. Zoetis leads the market share, while Elanco follows closely in this segment. Currently, these two companies are doing the most to mitigate the health and environmental consequences of the rising global demand for animal-derived products.

US Animal Biotechnology Market – Significant Growth Factors

The US Animal Biotechnology Market presents significant growth opportunities due to several factors:

• Technological advancement: The pace of innovation occurring in Genetic engineering, Genomics, and even AI-based diagnostics is leading to a change in the scope of animal biotechnology. Such technology was developed to make it possible to surveil and interfere with mechanisms that enhance the health status, productivity, and management of livestock. Hence, these changes are one of the reasons why this market sustains such growth.

• Increasing Consumption of Animal Products: The growing demand for meat and dairy products necessitates biotechnological approaches that improve livestock productivity. This would help stimulate capital investment in animal feed technologies that will enhance feed efficiency and in technologies that achieve a reliable supply of quality protein.

• Increased emphasis on Disease Control and Biosecurity: The foremost focus in this market is on intensive disease control and biosecurity. Involvement in battling new emerging animal diseases and biosecurity measures in the related field requires the use of biotechnology in better vaccines and diagnostics against outbreaks and in improving the health and safety of animals and food supply chains.

• Sustainability Initiatives: There is a strong possibility that biotechnological answers addressing sustainability in agriculture may emerge in the development. Innovations like low environmental input livestock production, resource efficiency, and environmentally friendly practices can easily fit with global objectives of sustainability, whose mandates come from authority.

• Consumer Demand for Transparency: Greater consumer demand to know what is produced leads to an innovation environment in traceability and better ethical conduct by biotechnology firms. Transparency and a commitment to animal welfare mean improved market appeal, consumer trust, and superior products.

US Animal Biotechnology Market – Key Developments

The US animal biotechnology market has witnessed many significant events in recent years. Players have been looking to increase their market footprint and leverage synergies to enhance product offerings and profitability. Some of the major mergers and acquisitions in the US Animal Biotechnology Market include:

• In 2022, Hester Biosciences Ltd announced that they have expanded into the pet care sector. Hester Biosciences is India’s second largest poultry vaccine maker. The Ahmedabad-based pharma firm is now trying to add dermatology, nutrition, grooming, anti-infective, and specialty products to the pet care segments.

• In 2022, Cadila Pharmaceuticals developed a novel three-dose recombinant nano-particle-based rabies G protein vaccine. The novel vaccine is set to be launched within the following months. The vaccine “Thrabis” is prepared using Virus-Like Particle technology (VLP).

Such developments help companies expand their product portfolio, strengthen their hold on the market and optimize their growth potential in the US Animal Biotechnology Market, which could keep growing.

US Animal Biotechnology Market – Significant Threats

Significant Threats in the US Animal Biotechnology Market include:

• Regulatory Challenges: Increased and ever-evolving regulatory affairs challenge the approval and development of new biotechnological products. Compliance with diversified state and federal regulations increases cost and timelines, meeting international standards as well.

• Ethical and Public Perception Concerns: What is concerned here are the ethical considerations of genetic modification as well as animal welfare that will determine public acceptance and consumer confidence. Given consumers’ poor perception of biotechnology, they tend to despise its consumption of biotechnological products and subject them to strict regulations.

• High Research and Development Costs: Innovating new biotechnological solutions through discovery, testing, and marketing is costly. It entails expensive capital outlays, and the risky venture scares firms, especially the small ones, off.

• Intellectual Property Disputes: The timing of market entry and innovation suffers judicial battles that slow the pace and increase the costs of operations for biotechnology firms while patents are contested in courts.

• Biosecurity Risks and Disease Outbreaks: Biosecurity risks and disease outbreaks reflect the potential risk of an unforeseen influence that biosecurity breaches or even new outbreaks of animal diseases, such as swine and avian flu, might have. Such events may affect the production factors, strain resources, and impair the efficiency of already available biotechnological solutions.

Category-Wise Insights

By Ingredient:

• Diagnostics Tests: Animal biotech diagnostics detect animal diseases, infections, and genetic diseases. Tests include blood tests, imaging, and molecular assays. Growth drivers in diagnostics tests are evolving molecular diagnostics, fast test development, and AI, which can provide more accurate readings. The tests also expand the market due to rising interest in early disease detection and personalized medicine.

• Vaccines and Drugs: Vaccines and drugs in livestock and companion animal biotechnology are preventive and therapeutic agents. This category includes vaccines against infectious diseases and therapeutics against several other diseases. This list of vaccines under development includes recombinant and DNA vaccines and, more recently, targeted therapies for chronic diseases among the significant growth drivers; hence, R&D investments and disease incidence are also demand drivers.

• Reproductive and Genetic: They are used in the production of animal breeding, genetics, and reproductive efficiency through genetic and reproductive techniques. This includes genetic testing, cloning, and embryo transfer. Improved gene editing through CRISPR systems, enhanced reproductive technology, and increased use of genetic tools for superior traits and productivity in livestock enhance the market.

• Feed Additives are chemical substances added to animal feeds to enhance health, growth, and performance. it involves vitamins, minerals, probiotics, and enzymes. Innovations are focused on improving feed efficiency and gut health and avoiding the negative environmental impacts on animal farming.

• Others: Besides the above categories, there are also all-new technologies and innovations in animal biotechnology. Examples are tissue engineering of animals and bioinformatics tools. Tissue engineering and advanced bioinformatics are among the newly emerging technologies. Innovations in these areas aim to improve animal welfare and make more tailored health solutions for animals.

By Application

• Diagnosis of Animal Diseases: The use of biotechnology in detecting and identifying animal diseases using high-end diagnostic equipment and techniques drives growth, propels progress in molecular diagnostics and artificial intelligence, and improves the accuracy and timeliness of early disease detection with results in better health management practices and a decrease in disease outbreak incidences through heightened interest in rapid, low-cost testing methods.

• Treatment of Animal Diseases: Using biotechnological advancements to design therapies to reduce or even alleviate animal diseases. Enhancement included targeted therapies, gene editing, and personalized medicine. There is an urgent need to discover successful treatments for emerging diseases and antibiotic-resistant infections to enhance animal health and welfare.

• Preventive Care of Animals: It encompasses biotechnological methods that prevent diseases to keep animals healthy, and vaccines and other preventive measures shall be utilized. Increasing application of high and new vaccines, probiotics, and immunomodulators to enhance animal welfare. Focus on creating better vaccine efficiency and novel preventive technologies to address new health issues occasionally, which will once again increase animal health benefits.

• Drug Development: The use of biotechnology to produce new pharmaceuticals, which is the research and development of animal drugs. Drug discovery and development investment is immense, from biologics to novel therapeutics. There is an emphasis on personalized veterinary medicine and biologics in treating complex diseases due to advancing technology and health-related issues.

• Others: Several other biotechnology applications are targeted at animal management, including genetic modification for desirable traits and biotechnology in breeding programs. There is enhancement growth in genetic engineering and CRISPR technology for trait enhancement and selective breeding. Innovations aim to enhance livestock for better productivity, disease resistance, and environmental adaptability.

By End Users

• Veterinary Laboratories: Veterinary laboratories function to test animal samples for disease and overall health. They now employ the newest biotechnological tools and technologies to execute sensitive testing and research functions. Trends include the rising adoption of molecular diagnostics and genomics to improve accuracy in detecting and monitoring disease, which compels sophisticated lab equipment and technologies.

• Point-of-Care Testing/In-house Testing: Point-of-care and in-house testing refer to diagnostics on-site or in veterinary practices. This further encompasses heightened demand for rapid, easy-to-use diagnoses that help expedite results-fastened diagnosis and ensure effective remedies. The segment will be helped by recent innovations in portable testing devices and the integration of diagnostic systems and technology.

• Veterinary Hospitals & Clinics: Veterinary hospitals and clinics employ biotechnological advances to provide complete diagnostic and monitoring treatment practices. The trends in veterinary hospitals and clinics are connected with advanced imaging trends, molecular diagnostics, and customized treatment options. Recent interest in preventive care, improved technology implementation, and revalidation quality assures better quality in veterinary service and its output concerning patient benefits.

• Others include research institutions, animal breeding centers, and pharmaceutical companies. Trends are to be related to investments in research and development in animal biotechnology, novel breeding technologies, animal welfare, and general productivity improvements in the industry.

Report Scope

Competitive Landscape – US Animal Biotechnology Market

The US Animal Biotechnology Market is highly competitive, with many manufacturers operating in the US. Some of the key players in the market include:

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Cargill Inc.
• BASF SE
• Alltech Inc.
• Heska Corporation
• Genus plc
• Neogen Corporation
• IDEXX Laboratories Inc.
• Aratana Therapeutics Inc.
• Vetoquinol S.A.
• Merial (part of Boehringer Ingelheim)
• Dechra Pharmaceuticals PLC
• Others

These companies operate in the market through various strategies such as innovation, mergers and acquisitions, and partnerships.

New entrants like Aratana Therapeutics and Eligo Bioscience have designed innovative products such as advanced gene editing and targeted therapeutics and can find a space in the animal biotechnology market. Advanced treatment and innovative technology address untapped needs. Market players like Zoetis Inc. and Elanco Animal Health have relied on robust R&D capacities, broader portfolios of products, and established reach. Continuous innovation, strategic acquisitions, and comprehensive global networks of distribution power their dominance.

The US Animal Biotechnology Market is segmented as follows:

By Product

• Diagnostics Tests
• Vaccines and Drugs
• Reproductive and Genetic
• Feed Additives
• Others

By Application          

• Diagnosis of Animal Diseases
• Treatment of Animal Diseases
• Preventive Care of Animals
• Drug Development
• Others

By End User

• Veterinary Laboratories
• Point-of-Care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others